-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AwDfk1RTTHk98dE8Fh/d0jl9e8mgZ9eyEyL5iVv2XvlMscq8nwsBK2eHZ6s4QC2D 89u7AT2y7Ui75LDKEu6GKg== 0001104659-06-055194.txt : 20060815 0001104659-06-055194.hdr.sgml : 20060815 20060815161747 ACCESSION NUMBER: 0001104659-06-055194 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060809 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20060815 DATE AS OF CHANGE: 20060815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 061035537 BUSINESS ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6504625900 MAIL ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 8-K 1 a06-18123_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  August 9, 2006

DEPOMED, INC.
(Exact name of registrant as specified in its charter)

001-13111
(Commission File Number)

California

 

94-3229046

(State or other jurisdiction of

 

(I.R.S. Employer Identification No.)

incorporation)

 

 

 

1360 O’Brien Drive, Menlo Park, California  94025
(Address of principal executive offices, with zip code)

(650) 462-5900
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 1.01               Entry into a Material Definitive Agreement

On August 9, 2006, Depomed, Inc. (the “Company”) entered into a lease agreement, effective as of July 28, 2006, with Menlo Business Park, LLC (“Menlo”) for approximately 9,255 square feet of general office space located at 1430 O’Brien Drive, Menlo Park, California.  The term of the lease is three years commencing on August 1, 2006, with an option exercisable by the Company to extend the lease term by five years.  The Company will pay approximately $15,733 per month in base rent, subject to adjustment under certain conditions, in addition to operating expenses and taxes for the lease term.

Also on August 9, 2006, the Company entered into amendments to its leases with Menlo for the Company’s premises at 1330 and 1360 O’Brien Drive, Menlo Park, California (the “Lease Amendments”).  The Lease Amendments, effective as of July 28, 2006, extend the term of the existing leases for fourteen months, through June 30, 2009, and provide for an option exercisable by the Company to further extend one or both of the lease terms for an additional five years.  All other material provisions of the leases remain the same, except for the monthly base rent during the extension periods, which will be $50,732 and $54,654 per month, respectively, beginning May 1, 2008, subject to adjustment under certain conditions, in addition to operating expenses and taxes for the duration of the lease term.

1



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

DEPOMED, INC.

 

 

 

 

 

 

Date:

August 15, 2006

 

By:

/s/ John F. Hamilton

 

 

 

 

John F. Hamilton

 

 

 

 

Vice President and

 

 

 

 

Chief Financial Officer

 

 

2


 -----END PRIVACY-ENHANCED MESSAGE-----